Litcius/Paper detail

The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways

Nazila Fathi Maroufi, Vahid Vahedian, Maryam Akbarzadeh, Mahshid Mohammadian, Mohammadsaeid Zahedi, Alireza Isazadeh, Farhad Pouremamali, Sina Taefehshokr, Masoud Heidari, Mohammad‐Reza Rashidi, Mohammad Nouri

2020Breast Cancer54 citationsDOI

Topics & Concepts

ApatinibMAPK/ERK pathwayCancer researchCell cycleApoptosisSignal transductionViability assayCell cycle checkpointp38 mitogen-activated protein kinasesKinaseProtein kinase ACell growthMedicineCancerBiologyCell biologyInternal medicineBiochemistryNF-κB Signaling PathwaysFlavonoids in Medical ResearchCytokine Signaling Pathways and Interactions
The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways | Litcius